This company seems to have been delisted
Reason: Acquired by Novo Holdings and Gurnet Point
Last recorded trade on: November 17, 2023
Source: https://www.reuters.com/markets/deals/novo-holdings-closes-462-mln-acquisition-paratek-pharmaceuticals-2023-09-21/
Reason: Acquired by Novo Holdings and Gurnet Point
Last recorded trade on: November 17, 2023
Source: https://www.reuters.com/markets/deals/novo-holdings-closes-462-mln-acquisition-paratek-pharmaceuticals-2023-09-21/
Paratek Pharmaceuticals
PRTK
C$3.03
Share price
0.00%
Change (1 day)
15.22%
Change (1 year)
Categories
Paratek Pharmaceuticals (PRTK) - Total liabilities
Total liabilities on the balance sheet as of June 2023 : C$0.47 Billion
According to Paratek Pharmaceuticals 's latest financial reports the company's total liabilities are C$0.47 Billion. A company’s total liabilities is the sum of all current and non-current debts and obligations.
Paratek Pharmaceuticals - Total liabilities on balance sheet (from 2004 to 2023)
Total liabilities by year
| Year | Total liabilities | Change |
|---|---|---|
| 2022-12-31 | C$0.46 B | 17.38% |
| 2021-12-31 | C$0.39 B | 11.6% |
| 2020-12-31 | C$0.35 B | -6.27% |
| 2019-12-31 | C$0.37 B | 10.34% |
| 2018-12-31 | C$0.34 B | 236.99% |
| 2017-12-31 | C$0.10 B | 18.47% |
| 2016-12-31 | C$86.19 M | 39.07% |
| 2015-12-31 | C$61.97 M | 262.26% |
| 2014-12-31 | C$17.1 M | 733.63% |
| 2013-12-31 | C$2.05 M | -22.5% |
| 2012-12-31 | C$2.64 M | -23.41% |
| 2011-12-31 | C$3.45 M | -65.4% |
| 2010-12-31 | C$9.99 M | -60.67% |
| 2009-12-31 | C$25.4 M | 651.39% |
| 2008-12-31 | C$3.38 M | -94.71% |
| 2007-12-31 | C$63.91 M | 779.78% |
| 2006-12-31 | C$7.26 M | -94.46% |
| 2005-12-31 | C$0.13 B | 27.56% |
| 2004-12-31 | C$0.10 B | |
| 2002-12-31 | C$77.14 M | 807.69% |
| 2001-12-31 | C$8.49 M |
Total liabilities for similar companies or competitors
| Company | Total liabilities | differencediff. | Country |
|---|---|---|---|
 Spectrum Pharmaceuticals
SPPI | C$0.11 B | -76.71% | 🇺🇸 USA |
 Agenus
AGEN | C$0.71 B | 50.54% | 🇺🇸 USA |
 Ultragenyx Pharmaceutical RARE | C$1.57 B | 234.34% | 🇺🇸 USA |